How to Check Bio Medica Laboratories IPO Allotment Status

Incorporated in August 2015, Bio Medica Laboratories specialises in manufacturing pharmaceutical parenteral formulations, producing a wide range of ethical drugs, generic drugs, and over-the-counter (OTC) medications in liquid and dry-powder injectable forms. These injectables are available in both single-dose and multi-dose formats, serving the needs of both human and veterinary healthcare.

Its product portfolio spans two key categories: Liquid Injectables (58 products) and Dry Powder Injectables (15 products). The company operates on a B2B model, focusing exclusively on contract manufacturing. It develops formulations for various companies in accordance with their specific requirements and product specifications, and is certified for Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP) by the Food & Drugs Administration, Madhya Pradesh. It has two manufacturing facilities in Indore, Madhya Pradesh.

Bio Medica Laboratories IPO is a book build issue of ₹52.43 crore, comprising a fresh issue of 0.34 crore shares aggregating to ₹47.19 crore and an offer for sale of 0.04 crore shares aggregating to ₹5.24 crore. The IPO opened on May 21, 2026, and closed on May 25, 2026. The allotment is expected on Tuesday, May 26, 2026. The share price band was set at ₹132 to ₹139 per share.

Don’t Miss Out on the Next Big IPO – Invest With Just a Few Clicks!

Open Account Now

Steps to Check Bio Medica Laboratories IPO Allotment Status on Registrar Site

• Visit the Skyline Financial Services Pvt. Ltd.
• Select "Bio Medica Laboratories" from the dropdown menu on the allotment status page
• Enter your PAN ID, Demat Account Number, or Application Number in the designated field
• Complete the captcha verification process and click on the "Submit" button to view your allotment status

Steps to Check Bio Medica Laboratories IPO Allotment Status on NSE

• Navigate to the NSE SME IPO Allotment Status Page
• Select the issue type: equity/debt
• Choose "Bio Medica Laboratories" from the list of active IPOs in the dropdown menu
• Input your Application Number and PAN ID in the required fields
• Verify the captcha and click "Search" to check your allotment status

Bio Medica Laboratories IPO subscribed 2.26 times overall. Here is the category-wise breakdown as of 5:14:59 PM on May 25, 2026:

Bio Medica Laboratories IPO Subscription Status

• QIB Category (Ex Anchor): 15.94 times
• Non-Institutional Investors (NII): 1.30 times
• Individual Investors: 2.92 times

Bio Medica Laboratories IPO Share Price and Investment Details

The minimum investment required was ₹2,78,000 for 2 lots (2,000 shares) for individual investors. The issue includes a reservation of up to 1,89,000 shares for the market maker, Prabhat Financial Services Ltd. Given the overall subscription of 2.26 times with strong institutional interest at 15.94 times, moderate NII participation at 1.30 times, and healthy individual investor subscription at 2.92 times, the share price listing expectations remain positive.

Utilisation of IPO Proceeds

The proceeds will be utilised for repayment of loan (₹6.50 crore), enhancement of existing production capabilities by setting up of a new manufacturing facility at the existing premises (₹28.50 crore), and general corporate purposes.

Business Overview

Bio Medica Laboratories Limited is engaged in the manufacturing and trading of pharma products in the B2B segment. Most of its business comes from contract manufacturing of pharma products. The company is operating in a highly competitive and fragmented segment.

The company demonstrated financial performance with total income of ₹38.33 crore for FY2025 and a net worth of ₹17.12 crore as of November 30, 2025. The company benefits from multi-product capability and a diversified product portfolio, experienced promoters, management, and employees, quality assurance, and established client relationships. However, investors should note the post-issue P/E ratio of 13.45 and Price to Book Value of 8.66.

Check the latest IPO allotment status to stay informed.